In aggregate, these findings reveal that LIF promotes CSCs stemness via JAK‐STAT3‐mediated SOX2 transcription in HNSCC, thus suggesting that chemical blockade of LIF‐LIFR‐STAT3 might be a promising therapeutic strategy for HNSCC (Figure 4O). The gene discussed is LIFR; the disease is head and neck squamous cell carcinoma.